Press release
Compounding Pharmacies Market to Hit US$ 14,995.1 million by 2028
Compounding pharmacies or compound pharmacy role is to mix ingredients as per patients' needs and manufacture drugs that are not commercially available. Pharmacy compounding has been present since the beginning of time. It is essential in cases such as limited dosage strengths and dosage forms, drug allergies to certain ingredients, pediatrics, chemotherapy and veterinary medicine. Further, compounded medicines enhance pharmacist contribution to developing and implementing patient therapeutic plans and provide customized medications of high pharmaceutical quality.The compounding pharmacies market was valued at US$ 9,442.8 million in 2020 and is projected to reach US$ 14,995.1 million by 2028; it is expected to grow at a CAGR of 6.1% from 2021 to 2028.
Get Sample Copy with Complete TOC and Figures & Graphs @ https://www.theinsightpartners.com/sample/TIPRE00005407/?utm_source=OpenPR&utm_medium=10357
Market leaders operating in the market have undertaken various organic growth strategies in the compounding pharmacies market. The compounding pharmacies market majorly consists of the players Fagron, Inc., Elixir Compounding Pharmacy, Avella specialty pharmacy, B. Braun Melsungen AG, PharMEDium Healthcare Holdings, Inc., Fresenius Kabi AG, Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd, Triangle Compounding Pharmacy, Vertisis Custom Pharmacy and US Compounding Inc. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies including mergers & acquisitions, partnership, and collaborations.
Pain Medications Segment to be Largest Contributor to Compounding Pharmacies Market During 2021-2028
Based on therapeutic area, the compounding pharmacies market is segmented into pain medications, hormone replacement therapies, dermatological applications, and others. The pain medications segment held the largest share of the market in 2020 and the same segment is estimated to register the highest CAGR in the market during the forecast period.
Purchase a Copy of this Report: https://www.theinsightpartners.com/buy/TIPRE00005407/?utm_source=OpenPR&utm_medium=10357
About Us:
The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, chemicals etc.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Compounding Pharmacies Market to Hit US$ 14,995.1 million by 2028 here
News-ID: 2830654 • Views: …
More Releases from The Insight Partners
Gastrointestinal Therapeutics and Diagnostics Market to Expand by 2031
The report, released on October 08, 2025, from New York, US, maps out the current market structure and predicts future trajectories, highlighting key opportunities, challenges, and the primary forces propelling its expansion. These findings are set to offer crucial strategic intelligence for various commercial stakeholders operating in the sector. According to the projections within the forecast, the GI market is expected to witness steady increases in its overall size, market…
High Purity Base Metals Market Powers Industrial Innovation
New York, US - October 08, 2025 - The Insight Partners has unveiled a new High Purity Base Metals Market report that underscores a promising growth trajectory fueled by technological advances and sustainability priorities. The demand for high-purity copper, aluminum, lead, and zinc is accelerating across industries such as electronics, transportation and construction, driven by a need for cleaner, more efficient materials.
Get Sample Copy of Report at: https://www.theinsightpartners.com/sample/TIPRE00016534/?utm_source=OpenPR&utm_medium=10188
The High Purity…
Smart Grid Top Companies Regional and Data Analysis to 2031
The Smart Grid Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits.
👉 Download the Report Here: https://www.theinsightpartners.com/sample/TIPTE100000319/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Smart Grid Market are:
• ABB Ltd.
• Alcatel-Lucent S.A.
• Eaton Corporation PLC
• General Electric Company
• Itron, Inc.
• Landis+Gyr AG
• Schneider Electric SE
• Sensus, Inc.
• Schweitzer Engineering Laboratories Inc.
Contact Us:
If you have any queries about this report or if you would like…
RF Front End Module Market Emerging Technological Growth, Future Growth and Busi …
The RF front end module market size is projected to reach US$ 7.58 billion by 2031 from US$ 3.89 billion in 2024. The market is expected to register a CAGR of 10.3% during 2025-2031.
The "RF Front End Module Market" forecast 2031 report analyses the present and future competitive scenario of the analytics industry. RF Front End Module Market report offers an in-depth analysis on segments including top companies, products,…
More Releases for Compounding
Compounding Pharmacies Business Development Strategies for Expanding Your Market …
The global compounding pharmacies market size was US$ 8.1 billion in 2021. The global compounding pharmacies market size is estimated to reach US$ 13.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2022 to 2030.
Request To Download Sample of This Strategic Report :-https://reportocean.com/industry-verticals/sample-request?report_id=bwcc17220
A compounding pharmacy is a distinctive kind of pharmacy. They can create customized medicines for the individual who…
NBR Compounding Market Report Status And Outlook 2022-2027-Hexpol Compounding, P …
The NBR Compounding Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of…
Global Compounding Pharmacies Market, Global Compounding Pharmacies Industry, Co …
The Compounding Pharmacies market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Compounding Pharmacies Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Compounding Pharmacies market. The report focuses on well-known providers in the global…
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market ; Eminent Players - Pencol Compounding Pharma …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market Key Players – McKesson Corporation, Nephron …
U.S. Compounding Pharmacies Market size is set to exceed USD 7 billion by 2025; according to a new research report by Global Market Insights, Inc.
Growing prevalence of chronic diseases in the U.S. such as cancer, diabetes, cardiovascular disease, respiratory diseases and obesity will drive the U.S. compounding pharmacies market growth over the forecast period. Increasing drug shortage in the country due to production delays and unavailability of previously manufactured…
